Related references
Note: Only part of the references are listed.Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients
Sondes Karray-Chouayekh et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
Zhe Jin et al.
CANCER RESEARCH (2009)
CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
Atsushi Tanemura et al.
CLINICAL CANCER RESEARCH (2009)
MHC Class II alleles in ulcerative colitis-associated colorectal cancer
M. M. Garrity-Park et al.
GUT (2009)
Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer
Megan M. Garrity-Park et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
Terje Ahlquist et al.
MOLECULAR CANCER (2008)
Inflammation: Gearing the journey to cancer
Joydeb Kumar Kundu et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil - Based chemotherapy
Lanlan Shen et al.
CLINICAL CANCER RESEARCH (2007)
Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
R. Horii et al.
BRITISH JOURNAL OF CANCER (2007)
Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias
Kazuo Konishi et al.
GASTROENTEROLOGY (2007)
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis
Cinzia Azzoni et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium
Tomomitsu Tahara et al.
DIGESTION (2007)
Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis
Edward V. Loftus
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2006)
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer
Quek Choon Lau et al.
CANCER RESEARCH (2006)
Chronic inflammation: A common and important factor in the pathogenesis of neoplasia
D Schottenfeld et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled, pilot study
WJ Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Prediction of colorectal neoplasia by quantitative methylation analysis of Estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis
K Tominaga et al.
CLINICAL CANCER RESEARCH (2005)
Aberrant methylation of cyclooxygenase-2 in breast cancer patients
LWC Chow et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis
S Fujii et al.
GUT (2005)
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk
K Schulmann et al.
ONCOGENE (2005)
Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer
Bao-Can Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Inflammation-associated cancer:: NF-κB is the lynchpin
QT Li et al.
TRENDS IN IMMUNOLOGY (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease
SH Itzkowitz et al.
INFLAMMATORY BOWEL DISEASES (2005)
Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression
R Soo et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2005)
Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs
DA van Heel et al.
HUMAN MOLECULAR GENETICS (2004)
Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma
TY Kim et al.
LABORATORY INVESTIGATION (2004)
Runx3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation
O Fainaru et al.
EMBO JOURNAL (2004)
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers
A Goel et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
SH Itzkowitz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia
O Brenner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CpG island methylation is a common finding in colorectal cancer cell lines
CM Suter et al.
BRITISH JOURNAL OF CANCER (2003)
Epigenetic control of the e-cadherin gene (CDHI) by CpG methylation in colectomy samples of patients with ulcerative colitis
P Azarschab et al.
GENES CHROMOSOMES & CANCER (2002)
Causal relationship between the loss of RUNX3 expression and gastric cancer
QL Li et al.
CELL (2002)
Surveillance issues in inflammatory Bowel disease - Ulcerative colitis
D Provenzale et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia
SN Agoff et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)